The companies are a unique blend of talented researchers and aspiring companies all striving for innovation in their designated discipline.
While the Park is made up of many individual companies, it functions as a community with encouraged cooperative communication between the tenants.
Nimble Therapeutics has designed a core technology that is powered by a massively parallel chemical synthesis platform. We’ve aired this with a variety of molecule enhancing assay capabilities and robust chemo-informatics to enable rapid discovery and optimization of peptidic compounds with drug-like properties.